Fig. 4From: Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinomaSpheroid formation assay—EpCAM-targeted therapy either in single or in combination inhibit the cells which responsible for form spheroids. a Control. b Cisplatin. c XAV9393. d. XAV3939 + cisplatin. e shRNA (EpCAM). f shRNA (EpCAM) + cisplatinBack to article page